LifeCall receives funding from Horizon 2020 SME Instrument Phase 1 EU Program March 2018, We, Sensencall, a private R&D, Izmir-Turkey based technology company specializes in R&D studies and production of healthcare, medical, diagnostic devices and IoT systems, have received the funding from H2020 SME Instrument Phase 1 program to conduct further studies of our LifeCall ECG project. LifeCall is an innovative system which aims to create an affordable, reliable, comfortable, electrodeless, wearable ECG heart health monitoring, analysis and warning device, a daily wearable simple shirt and strap. It can be used daily for a long term with no negative effects on users’ day to day life. This system will save many lives by analyzing and gathering data for long-term heart monitoring and many other bio signals.
This project has received funding from the Europan Union’s Horizon 2020 research and innovation programme under grant agreement No 809158